Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 9—September 2015
THEME ISSUE
Emerging Infections Program
Emerging Infections Program

Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae

Nora Chea, Sandra N. Bulens, Thiphasone Kongphet-Tran, Ruth Lynfield, Kristin Shaw, Paula Snippes Vagnone, Marion Kainer, Daniel Muleta, Lucy Wilson, Elisabeth Vaeth, Ghinwa Dumyati, Cathleen Concannon, Erin C. Phipps, Karissa Culbreath, Sarah J. Janelle, Wendy Bamberg, Alice Y. Guh, Brandi M. Limbago, and Alexander J. KallenComments to Author 
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (N. Chea, S.N. Bulens, T. Kongphet-Tran, A.Y. Guh, B. Limbago, A.J. Kallen); Minnesota Department of Health, St. Paul, Minnesota, USA (R. Lynfield, K.M. Shaw, P. Snippes Vagnone); Tennessee Department of Health, Nashville, Tennessee, USA (M.A Kainer, D.B. Muleta); Maryland Emerging Infections Program, Baltimore, Maryland, USA (L. Wilson, E. Vaeth); New York–Rochester Emerging Infections Program, Rochester, New York, USA (G. Dumyati, C. Concannon); University of Rochester Medical Center, Rochester (G. Dumyati, C. Concannon); University of New Mexico, Albuquerque, New Mexico, USA (E.C. Phipps, K. Culbreath); Colorado Department of Public Health and Environment, Denver, Colorado, USA (S.J. Janelle, W.M. Bamberg)

Main Article

Table 1

Summary of 11 phenotype-based definitions evaluated for reliability in identifying carbapenemase producers among carbapenem-resistant Enterobacteriaceae, United States, January 1, 2011–January 30, 2014*

Antimicrobial included Study inclusion criteria Definition†
1 2 3 4 5 6 7 8 9 10 11
Any carbapenem‡ NS R R R NS§ R
Any carbapenem (without ertapenem) NS NS NS R NS
>2 carbapenems‡ NS§
All third-generation cephalosporins tested R R
Any third-generation cephalosporins tested R R
Cefepime R R R

*NS, nonsusceptible; R, resistant. Blank cells mean not included in the definition.
†Interpretation based on Clinical and Laboratory Standards Institute breakpoints (M100-S23) (11). Definitions: 1, nonsusceptible to any carbapenem, excluding ertapenem; 2, nonsusceptible to any carbapenem, excluding ertapenem, and resistant to all third-generation cephalosporins tested (pre-2015 Centers for Disease Control and Prevention carbapenem-resistant Enterobacteriaceae surveillance definition); 3, nonsusceptible to any carbapenem, excluding ertapenem, and resistant to any third-generation cephalosporins tested; 4, resistant to any carbapenem; 5, resistant to any carbapenem, excluding ertapenem; 6, resistant to any carbapenem and resistant to all third-generation cephalosporins tested; 7, resistant to any carbapenem and resistant to any third-generation cephalosporin tested; 8, nonsusceptible to at least 2 carbapenems (ertapenem resistant, if tested); 9, nonsusceptible to any carbapenem (ertapenem resistant, if tested) and resistant to cefepime; 10, resistant to any carbapenem and resistant to cefepime; and 11, nonsusceptible to any carbapenem, excluding ertapenem, and resistant to cefepime.
‡Ertapenem, doripenem, imipenem, and meropenem.
§If ertapenem used in the definition, isolate would need to be resistant (i.e., MIC >2 μg/mL).

Main Article

References
  1. Spellberg  B, Guidos  R, Gilbert  D, Bradley  J, Boucher  HW, Scheld  WM, The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:15564. DOIPubMedGoogle Scholar
  2. Smolinski  MS, Hamburg  MA, Lederberg  J. Microbial threats to health: emergence, detection, and response. Washington: The National Academies Press; 2003.
  3. Gupta  N, Limbago  BM, Patel  JB, Kallen  AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53:607. DOIPubMedGoogle Scholar
  4. Centers for Disease Control and Prevention. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep. 2013;62:16570 .PubMedGoogle Scholar
  5. Lee  CS, Vasoo  S, Hu  F, Patel  R, Doia  Y. Klebsiella pneumoniae ST147 coproducing NDM-7 carbapenemase and RmtF 16S rRNA methyltransferase in Minnesota. J Clin Microbiol. 2014;52:410910. DOIPubMedGoogle Scholar
  6. Mathers  AJ, Hazen  KC, Carroll  J, Yeh  AJ, Cox  HL, Bonomo  RA, First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the “menace” arrives in the new world. J Clin Microbiol. 2013;51:6803. DOIPubMedGoogle Scholar
  7. Centers for Disease Control and Prevention. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep. 2009;58:25660 .PubMedGoogle Scholar
  8. Epstein  L, Hunter  JC, Arwady  MA, Tsai  V, Stein  L, Gribogiannis  M, New Delhi metallo-β-lactamase–producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA. 2014;312:144755. DOIPubMedGoogle Scholar
  9. Epson  EE, Pisney  LM, Wendt  JM, MacCannell  DR, Janelle  SJ, Kitchel  B, Carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-β-lactamase at an acute care hospital, Colorado, 2012. Infect Control Hosp Epidemiol. 2014;35:3907. DOIPubMedGoogle Scholar
  10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-fourth informational supplement. M100-S24. Wayne (PA): The Institute; 2014.
  11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement. M100-S23. Wayne (PA): The Institute; 2013.
  12. Rasheed  JK, Kitchel  B, Zhu  W, Anderson  KF, Clark  NC, Ferraro  MJ, New Delhi metallo-β-lactamase–producing Enterobacteriaceae, United States. Emerg Infect Dis. 2013;19:8708. DOIPubMedGoogle Scholar
  13. Nordmann  P, Poirel  L. Strategies for identification of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2013;68:4879. DOIPubMedGoogle Scholar
  14. Tijet  N, Boyd  D, Patel  SN, Mulvey  MR, Melano  RG. Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2013;57:457880. DOIPubMedGoogle Scholar
  15. Voulgari  E, Poulou  A, Koumaki  V, Tsakris  A. Carbapenemase-producing Enterobacteriaceae: now that the storm is finally here, how will timely detection help us fight back? Future Microbiol. 2013;8:2739. DOIPubMedGoogle Scholar
  16. Nordmann  P, Poirel  L, Dortet  L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012;18:15037. DOIPubMedGoogle Scholar

Main Article

Page created: August 12, 2015
Page updated: August 12, 2015
Page reviewed: August 12, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external